Vaghasiya Kalpesh, Sharma Ankur, Kumar Kushal, Ray Eupa, Adlakha Suneera, Katare Om Prakash, Hota Sunil Kumar, Verma Rahul K
Institute of Nano Science and Technology (INST), Phase X, Sector 64, Mohali, Punjab 160062, India.
Defence Institute of High Altitude Research, Defence Research and Development Organisation, C/o 56 APO, Leh-Ladakh, Jammu and Kashmir 901205, India.
ACS Biomater Sci Eng. 2019 Dec 9;5(12):6617-6631. doi: 10.1021/acsbiomaterials.9b01486. Epub 2019 Nov 21.
The critical time window between the incidence of frostbite injury and the initiation of treatment in remote snowbound areas is a determining factor for an effective therapeutic response. It is an emergency condition and challenging to treat due to the poor vascularity of affected body parts, and it requires immediate action. In addition to cold trauma-induced tissue damage, the inflammatory mediators majorly contribute to pathologic aggravations. We have designed and evaluated a topical "nano-spray gel (NSG)" formulation, which is based on a combination of liposomal heparin sodium (Hp) and ibuprofen (Ibu) for rapid relief of frostbite injury in extremely low temperatures. The scientific literature suggests that heparin is associated with rapid endothelial cell repair, normalizing blood circulation in capillaries, and has a potential role in wound healing. Hp-containing liposomes were prepared by the extruder method, which suitably formulated an ibuprofen-containing gel to obtain a nano-Spray formulation (HLp-Ibu-NSG) applicable for topical delivery. A single spray puff of the formulation delivers ∼154 mg of the gel, which corresponds to ∼205 U of heparin. In this study, heparin liposomes exhibited significant healing of wound in vitro (scratch assay, fibroblast cells) and in vivo (wound healing in Sprague Dawley rats) at a low dose. In the rat model of frostbite injury, the HLp-Ibu-NSG formulation demonstrated significant reduction in the wound area (up to ∼96%) and improvement of histopathology in 14 days as compared to the control groups. No edema and erythema were detected post-treatment of HLp-Ibu-NSG in the affected area. The underlying mechanism was delineated as a modulation of the inflammatory cytokine (IL-6, TNF-α, IL-10, IL-4) mediators at the wound site and blood circulation to foster frostbite healing. Future clinical studies on the nano-spray gel are required to evaluate its efficacy for the treatment of frostbite symptoms. The instant on-site application of this formulation might be helpful in saving extremities of soldiers, mountaineers, and pilgrims having frostbite.
在偏远的积雪地区,从冻伤发生到开始治疗的关键时间窗是有效治疗反应的决定性因素。这是一种紧急情况,由于受影响身体部位血管状况不佳,治疗具有挑战性,需要立即采取行动。除了冷损伤诱导的组织损伤外,炎症介质在病理加重中起主要作用。我们设计并评估了一种局部用“纳米喷雾凝胶(NSG)”制剂,它基于脂质体肝素钠(Hp)和布洛芬(Ibu)的组合,用于在极低温度下快速缓解冻伤。科学文献表明,肝素与内皮细胞快速修复、使毛细血管血液循环正常化有关,并且在伤口愈合中具有潜在作用。含Hp的脂质体通过挤压法制备,将其与含布洛芬的凝胶适当配制以获得适用于局部给药的纳米喷雾制剂(HLp-Ibu-NSG)。该制剂单次喷雾可递送约154毫克凝胶,相当于约205单位肝素。在本研究中,肝素脂质体在低剂量时在体外(划痕试验、成纤维细胞)和体内(Sprague Dawley大鼠伤口愈合)均表现出显著的伤口愈合效果。在冻伤大鼠模型中,与对照组相比,HLp-Ibu-NSG制剂在14天内伤口面积显著减小(高达约96%),组织病理学得到改善。HLp-Ibu-NSG治疗后在受影响区域未检测到水肿和红斑。其潜在机制被描述为对伤口部位炎症细胞因子(IL-6、TNF-α、IL-10、IL-4)介质的调节以及促进冻伤愈合的血液循环。未来需要对纳米喷雾凝胶进行临床研究以评估其治疗冻伤症状的疗效。这种制剂的即时现场应用可能有助于挽救患有冻伤的士兵、登山者和朝圣者的肢体。